Description
Tesamorelin is a synthetic analogue of Growth Hormone-Releasing Hormone (GHRH) comprising the 44 amino acid sequence of human GHRH with a trans-3-hexenoic acid group added to the N-terminus. This modification improves stability and resistance to enzymatic degradation, allowing for more sustained stimulation of the pituitary gland to release endogenous growth hormone. It is primarily researched for its efficacy in reducing excess visceral adipose tissue (VAT) and improving metabolic profiles in clinical models of lipodystrophy.

Reviews
There are no reviews yet.